Literature DB >> 26678176

Determination of parthenolide in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.

Ai-qin Zhao1, Ji-hong Zhao2, Shu-qing Zhang1, Yong-yang Pan3, Xu-lei Huo3.   

Abstract

A rapid, sensitive and selective ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method was developed and validated for the determination and pharmacokinetic investigation of parthenolide in rat plasma. Sample preparation was accomplished through a simple one-step deproteinization procedure with 0.2mL of acetonitrile containing 30ng/mL of pirfenidone (IS), and to a 0.1mL plasma sample. Plasma samples were separated by UPLC on an Acquity UPLC BEH C18 column using a mobile phase consisting of acetonitrile-0.1% formic acid in water with gradient elution. The total run time was 3.0min and the elution of parthenolide was at 1.33min. The detection was performed on a triple quadrupole tandem mass spectrometer in the multiple reaction-monitoring (MRM) mode using the respective transitions m/z 249.2→231.1 for parthenolide and m/z 186.2→92.1 for pirfenidone (IS), respectively. The calibration curve was linear over the range of 2.0-500ng/mL with a lower limit of quantitation (LLOQ) of 2.0ng/mL. Mean recovery of parthenolide in plasma was in the range of 78.2-86.6%. Intra-day and inter-day precision were both <8.3%. This method was successfully applied in pharmacokinetic study after oral and intravenous administration of parthenolide in rats.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Parthenolide; Pharmacokinetics; Rat plasma; UPLC-MS/MS

Mesh:

Substances:

Year:  2015        PMID: 26678176     DOI: 10.1016/j.jpba.2015.11.039

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Comparison of the Effect of Tanacethum Parthenium, 5-Hydroxy Tryptophan, and Magnesium (Aurastop) versus Magnesium Alone on Aura Phenomenon and Its Evolution.

Authors:  Giorgio Dalla Volta; Paola Zavarise; Laura Perego; Lidia Savi; Alessandro Pezzini
Journal:  Pain Res Manag       Date:  2019-10-09       Impact factor: 3.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.